Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent

Pathologie Biologie

Volumn 55, Issue 3-4, 2007, Pages 198-200

  Lissoni, P ^a  

^a Division of Radiation Oncology   (Italy)

Author keywords

Anticancer hormones; Melatonin; Methoxytryptamine; Pineal gland

Indexed keywords

5 METHOXYTRYPTAMINE; ANTIINFECTIVE AGENT; CISPLATIN; ETOPOSIDE; MELATONIN; PINEAL BODY HORMONE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUROTOXICITY; THROMBOCYTOPENIA;

5-METHOXYTRYPTAMINE; AGED; ANOREXIA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HORMONES; HUMANS; LUNG NEOPLASMS; MALE; MELATONIN; MIDDLE AGED; PINEAL GLAND; PINEALOMA;

EID: 34249716813     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2006.12.008     Document Type: Article

References (5)

1. Bartsch H., and Bartsch C. Effect of melatonin on experimental tumors under different photoperiods and times of administration. J. Neural Transm. 52 (1981) 269-279
2. Brzezinski A. Melatonin in human. N. Engl. J. Med. 336 (1997) 185-195
3. Sze S., Liu W., and Ng T. Stimulation of murine splenocytes by melatonin and methoxytryptamine. J. Neural Transm. Gen. Sect. 94 (1993) 115-126
4. Maestroni G.J.M. The immunoneuroendocrine role of melatonin. J. Pineal Res. 14 (1993) 1-10
5. Lissoni P., Barni S., Mandala M., Ardizzoia A., Paolorossi F., Vaghi M., et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 35 (1999) 1688-1692